TRANSLATIONAL AND CLINICAL MEDICINE - Georgian Medical Journal

Background: Cardiac myxoma is most common primary cardiac neoplasm, but due to uncertain histogenesis and discussing immunohistochemical profile, is actually studding.

Aim of Study: To assess of immunihistochemical priority to diagnosis of cardiac myxoma type and development.

Methods: 13 cardiac myxomas were histologically and immunohistochemically investigated considering clinical data in results.

Results: The expression of Vimentin, Epithelial markers (CK7,CK19), pro-inflammatory CD 68 and CD 117 signal markers in myxomas parenchyma indicated on the presence of different myxoid cells and various differentiated stromal components, middle inflammatory reaction, hemosiderosis and multipotential mesenchyme precursors.

Conclusion: Diffuse cytoplasmic neuropeptide S100 protein and Calretinin immunoreactivities represent mainly mesenchyme derived endothelial and capable neural differentiation.

Cohen R, Singh G, Mena D, Garcia CA, Loarte P, Mirrer B. Atrial Myxoma: A Case Presentation and Review. Cardiol. Res. 2012, 3(1), 41-44.

Zhang M, Ding L, Liu Y, Xue L. Cardiac myxoma with glandular elements: a clinicopathological and immunohistochemical study of five new cases with an emphasis on differential diagnosis. Pathology, Reserch and Practice. 2014, 210(1):55-58. DOI: 10.1016/j.prp.2013.09.018

Hernández-Bringas O, Ortiz-Hidalgo C. Histopathological and immunohistochemical features of cardiac myxomas. Arch. Cardiol. Mex., 2013, 83(3):199-208. doi: 10.1016/j.acmx.2013.02.002.

Rogov KA, Kaktursky LV, Mikhailova LP. On the histogenesis of cardiac myxoma. Arkhiv Patologii 80(3):3 2018. DOI: 10.17116/patol20188033-10

Тодоров СС, Сидоров РВ, Дерибас ВЮ, Казьмин АС, Кузнецов ИИ, Насытко АД. К вопросу о гистогенезе миксомы сердца. Электронный научный журнал Современные проблемы науки и образования, 2019, № 1.

Di Vito A, Mignogna C, Donato G.The mysterious pathways of cardiac myxomas: a review of histogenesis, pathogenesis and pathology. Histopathology, 2015, 66(3): 321-32. doi: 10.1111/his.12531.

Val-Bernal JF, Acebo E, Gómez-Román JJ, Garijo MF. Anticipated diagnosis of left atrial myxoma following histological investigation of limb embolectomy specimens: a report of two cases. Pathol Int. 2003, 53(7):489-94. DOI: 10.1046/j.1440-1827.2003.01504.x

Di Vito A, Santise G, Mignogna C, Chiefari E, Cardillo G, Presta I, et al. Innate immunity in cardiac myxomas and its pathological and clinical correlations. Innate Immun. 2018, 24(1):47-53. doi: 10.1177/1753425917741678.

Flint N, Siegel RJ, Bannykh S, Luthringer DJ. Bi-atrial cardiac myxoma with glandular differentiation: a case report with detailed radiologic-pathologic correlation. European Heart journal. Case Reports, 2018, 2(2). DOI: 10.1093/ehjcr/yty045

Nath D, Arava S, Ray R, Bhoje AK, Saxena R, Chaudhary SK. Immunohistochemical characterization of glandular elements in glandular cardiac myxoma: Study of six cases. Indian J Pathol Microbiol. 2017, 60(3):319-323. doi: 10.4103/IJPM.IJPM_225_16.

Gošev I, Paić F, Durić Z, Gošev M, Ivčević S, Jakuš FB, et al. Cardiac myxoma the great imitators: comprehensive histopathological and molecular approach. Int J Cardiol. 2013, 164(1):7-20. doi: 10.1016/j.ijcard.2011.12.052.

Pucci A, Gagliardotto P, Zanini C, Pansini S, di Summa M, Mollo F. Histopathologic and clinical characterization of cardiac myxoma: review of 53 cases from a single institution. Am Heart J. 2000, 140(1):134-8. DOI: 10.1067/mhj.2000.107176

Pucci A, Bartolini G, Tessitore E, Carney JA, Papotti M. Cytokeratin profile and neuroendocrine cells in the glandular component of Cardiac myxoma. Virchow Arch 2003, (443): 618-24. DOI: 10.1007/s00428-003-0882-3

Curschellas E, Toia D, Borner M, Mihatsch MJ, Gudat F. Cardiac myxomas: Immunohistochemical study of benign and malignant variants. Virchows Arch A Pathol Anat Histopathol. 1991, 418(6):485-91. DOI: 10.1007/BF01606497

Yokomuro H, Yoshihara K, Watanabe Y, Shiono N, Koyama N, Takanashi Y. The variations in the immunologic features and interleukin-6 levels for the surgical treatment of cardiac myxomas. Surg Today. 2007, 37(9):750-3. DOI: 10.1007/s00595-006-3448-6

WMA Declaration of Helsinki – Ethical Principles for Medical Research Involving Human Subjects. 2013.

Terracciano LM, Mhawech P, Suess K, D'Armiento M, Lehmann FS, Jundt G, et al. Calretinin as a marker for cardiac myxoma. Diagnostic and histogenetic considerations. Am J Clin Pathol. 2000, 114(5):754-9. DOI: 10.1309/NR6G-T872-F090-LBRW

Alassal M, Altargami N, Ahmed H, Ibrahim S, Nemlander A, Aldahmashi M, et al. An Unusual Presentation of Cardiac Myxoma; a Case Report and Review of Literature. American Journal of Cardiovascular and Thoracic Surgery 2019. DOI: 10.15226/2573-864X/4/2/00158

Wang JG, Li YJ, Liu H, Li NN, Zhao J, Xing XM. Clinicopathologic analysis of cardiac myxomas: Seven years' experience with 61 patients. J Thorac Dis. 2012, 4(3):272-83. doi: 10.3978/j.issn.2072-1439.2012.05.07.

Yang L, Zhang Y. Tumor-associated macrophages: from basic research to clinical application. Journal of Hematology & Oncology 2017, 10(1). DOI: 10.1186/s13045-017-0430-2

Donato G, Conforti F, Camastra C, Ammendola M, Donato A, Renzulli A. The role of mast cell tryptases in cardiac myxoma: Histogenesis and development of a challenging tumor. Oncol Lett. 2014, 8(1):379-383. DOI: 10.3892/ol.2014.2104